Medical Science Liaison - Dallas/Fort Worth TX
Gilead Sciences- Full Time
- Junior (1 to 2 years)
Candidates should possess a Doctor of Pharmacy (PharmD) degree or equivalent, along with a strong understanding of pharmaceutical sales and medical affairs. A minimum of 8 years of experience in medical affairs, specifically within a field medical advisor role, is required, with demonstrated success in Texas, Louisiana, and Arkansas preferred. Experience with mRNA technology or vaccines is highly desirable. Excellent knowledge of US healthcare systems, regulatory guidelines, and medical terminology is essential.
As an Associate Director, Field Medical Advisor, you will be responsible for developing and executing territory engagement plans to share Moderna’s science and data effectively with the medical and healthcare community. You will utilize excellent communication skills to simplify complex scientific topics and gather insights from healthcare professionals, including Key Opinion Leaders and scientific societies. This role involves strategic engagement, medical intelligence gathering, stakeholder interaction, scientific dialogue, and the management of medical strategies, including advisory boards and conferences. Furthermore, you will ensure compliance with ethical standards and accurately document activities in the CRM system, reporting adverse events and product quality complaints, while collaborating to enhance patient care and outcomes.
Develops mRNA-based medicines for health
Moderna focuses on developing medicines using messenger RNA (mRNA), which is a crucial component in how cells produce proteins necessary for biological functions. Their approach involves creating a new class of medicines that utilize mRNA to instruct cells to produce specific proteins, potentially leading to significant advancements in treating diseases. Unlike traditional pharmaceuticals, which often rely on chemical compounds, Moderna's mRNA-based therapies aim to enhance the discovery, development, and manufacturing processes of medicines. The company's goal is to improve patient outcomes by harnessing the power of mRNA to create effective treatments.